26-Mar-2020 | Facts and Factors
The global Cancer Supportive Care Drug market in 2019 is approximately USD 21,230.12 Million. The market is anticipated to grow at a CAGR of 1.1% and is projected to reach around USD 22,760.32 Million by 2026.
Cancer is a group of diseases, describe as abnormal cell growth which may not or may move to the other part of the body. In order to control cancer, many drug therapies are prescribed by a physician. A supportive drug is a medicine that is not the active part of therapy but is incorporated into the remedy for the better management of disorders. The various drug used as supportive drugs are G-CSFs, Bisphosphonates, Antiemetics, Opioids, NSAIDs, ESAs, and Others.
Browse the full “Cancer Supportive Care Drug Market by Product Type By Type (G-CSFs, Bisphosphonates, Antiemetics, Opioids, NSAIDs, ESAs, and Others), By Distributor Channel (Hospital, Pharmacy, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026" https://www.fnfresearch.com/cancer-supportive-care-drug-market-by-product-type-937
The cancer supportive care drug market is highly driven by an increasing number of cancer-related disorders across the world. In addition, the increasing aging population in Europe and North America is also one of the major factors driving the growth of the market. Furthermore, an increasing portion of the population with high per capita healthcare expenditures coupled with early detection is one of the major driving factors for this market. Various factors such as increasing the use of immune-oncology agents and other alternatives may restrain the growth of the market. Increasing research and development and pipeline drugs may be considered as futuristic opportunities within the forecast periods.
In product type, the market is classified into seven types G-CSFs, Opioids, Antiemetics, Bisphosphonates, ESAs, NSAIDs, and Others. At present, G-CSFs used for neutropenia (CIN), For Anemia ESAs (CIA), for nausea and vomiting; antiemetics (CINV), bisphosphonates for cancer-induced bone diseases, and NSAIDs and opioids for the treatment of cancer pain. In terms of therapeutic Class, granulocyte stimulating factors accounted for the largest market shares in the year 2019 and the same remains continuous within the forecasted year followed by opioids.
Based on end-users, the market is classified into Specialty clinics, hospitals, direct consumer,s and others. Public and Private Hospitals combined account for the largest market shares in the year 2019. This segment accounts for around more than 70% of market shares in the year 2019.
North America accounts for the largest market share in the year 2019. As per our analysis, North America accounted for more than 40% of the market share in the year 2019. Fast treatment, Public awareness, a High literacy rate, and advanced healthcare infrastructures are some of the major factors driving this region. The European Market is mainly driven by countries like the UK, Germany, France, Italy, and Spain. High per capita income is one of the major driving factors for this country. Brazil is the major driving country for the Latin America Market. Brazil contributes more than half of the revenue shares in the Latin American Region.
Report Scope
Report Attribute |
Details |
Market Size in 2019 |
USD 21,230.12 Million |
Projected Market Size in 2026 |
USD 22,760.32 Million |
CAGR Growth Rate |
1.1% CAGR |
Base Year |
2020 |
Forecast Years |
2020-2026 |
Key Market Players |
Amgen, Merck, Novartis, Johnson & Johnson, Roche, Helsinn Healthcare, Heron Pharma, Tesaro, and Purdue Pharma amongst others. |
Key Segment |
By Distribution Channel, By Type, By Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Some of the major players operating in Amgen, Merck, Novartis, Johnson & Johnson, Roche, Helsinn Healthcare, Heron Pharma, Tesaro, and Purdue Pharma amongst others.
This report segments the Cancer Supportive Care Drug market as follows:
Global Cancer Supportive Care Drug Market: Type Segment Analysis
- G-CSFs
- Bisphosphonates
- Antiemetics
- Opioids
- NSAIDs
- ESAs
- Others
Global Cancer Supportive Care Drug Market: Distribution Channel Segment Analysis
Global Cancer Supportive Care Drug Market: Regional Segment Analysis
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest Of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- The Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East & Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction in our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A - 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
